Global laboratory proficiency testing market was worth USD 1.1 billion in 2019. It is projected to grow at a compound annual rate (CAGR of 7.3%) between 2020 and 2027. This growth is due to strict regulations and a greater focus on diagnostic labs as a result of the COVID-19 pandemic. Market growth is expected to be driven by the increasing number of proficiency testing programs that are being offered by major players. Proficiency testing ensures that tests to detect the novel coronavirus have been correctly interpreted, processed and administered in a way that is accurate and reliable. Proficiency tests give laboratories the assurance that they are correctly diagnosing the virus.
In all areas affected by the pandemic, proficiency testing is essential. Numerous organizations have taken initiatives to address the problems that laboratories face in accreditation and to increase market growth. In November 2020, for example, the WHO and European Civil Protection and Humanitarian Aid Operations, (ECHO), partnered with the Department of Health (DOH), and local governments to train and ensure accreditation of testing labs.
Market growth is expected to be accelerated by the increasing incidence of foodborne illnesses caused by unsafe foods containing bacteria, chemicals, and parasites. The WHO estimates that around 600 million people, or approximately 1 in 10, will be affected by illnesses caused by eating contaminated foods. This could lead to 420,000 deaths each year. More than 200 diseases can be caused by food contaminants, including cancer and diarrhea.
Legalization of cannabis products in the U.S.A in December 2018 and its gradual expansion are driving the need to test safety and effectiveness for medical use. Laboratory that can specifically measure the potency of cannabis have been created in response to growing demand for high-potency marijuana. Market growth will be boosted by the introduction of regulations that test for potency and contaminants.
In 2019, the clinical diagnostics segment was responsible for 34.5% of all revenue. The largest revenue share of 34.5% was attributed to clinical diagnostics. Proficiency testing can also improve efficiency, reproducibility, accuracy, and quality of clinical diagnostics.
The clinical diagnostics segment can be subdivided into clinical chemicals, immunochemistry and hematology. Due to the presence in this segment of immunochemistry tests for allergies, autoimmune disease, hormones and infectious diseases, urine electrophoresis and serum electrophoresis as well as immunoglobulin, the segment held a significant market share in 2019.
Quality control laboratories play an important role in pharmaceutical quality control. These laboratories must constantly assess their own performance. LGC offers the PHARMASSURE Program to meet the needs of the pharmaceutical industry. This includes all necessary tests such as microbiology, chemical, and endotoxin.
In 2019, hospitals accounted for 32.8% of the total market. Due to the large usage by patients and doctors, the diagnostic laboratories segment will see the most growth in the future. This segment can be further divided into specialty and independent laboratories. For specimens, diagnostic labs must compete with hospitals. These labs have a competitive advantage because they offer a wide variety of tests in a short time.
Major hubs of production and R&D are the pharmaceutical and companies. In the biotechnology and pharmaceutical industries, proficiency testing can be used to validate lab efficacy and ensure accuracy. Companies can also modify or correct processes that do not conform to regulatory guidelines. This will ensure the FDA approves the final product.
The forecast period will see significant growth in contract research organizations. CROs are mainly located in emerging economies like India and China. The scope of laboratory proficiency testing via CROs will be expanded by strict FDA guidelines concerning R&D and clinical trials.
In 2019, the cell cultivation segment had a 30.4% revenue share. This segment is expected to grow at a significant rate over the next years due to its ability to detect infectious microorganisms within blood. These tests are used in the pharmaceutical industry to verify the effectiveness of cell culture-based products and vaccines. Cell culture tests have been more popular due to the increased adoption of cell-culture-based products such as monoclonal antibody. This allows for maximum production from microbial strains. This segment offers proficiency tests to assess the effectiveness of laboratories and detect contaminants in cell cultures.
Due to its ability to detect specific antibodies or antigens in blood, the immunoassays market segment held a significant share of the 2019 market. They can be performed in both labs and on-site. They can also be used to quantify any analytes present in blood using immunological reactions.
Chromatography has many advantages, including safety and reliability. Merck, for example, offers a comprehensive gas chromatography proficiency test material at a price as low as USD 257 to ensure that the device is reliable and efficient. To meet the specific needs of the pharmaceutical industry, HPLC is available in the PHARMASSURE scheme at LGC.
North America was the country with the largest revenue share, 44.2%, in 2019. It is expected to continue its lead during the forecast period. This can be attributed to the strict regulatory framework and increasing adoption of proficiency testing. The growth of the region market will also be aided by the presence of large players in the U.S.
Asia Pacific will experience the fastest CAGR at 9.5% over the forecast period. Market growth is expected to be driven by increasing healthcare awareness and the growing number of laboratories applying for accreditations internationally in the region.
High-level complexity is a hallmark of the market for proficiency testing in laboratory laboratories. This market includes products that test proficiency and competency of laboratories. It also has quarterly and annual testing.
Due to the rapid adoption of new technology by laboratories to process samples, proficiency testing saw a rise in demand. The government has also played an important role in proficiency testing to obtain better statistics about the pandemic. The market will see an increase in demand.
In order to increase their product range, manufacturing capabilities, and competitive differentiation, companies are engaging in mergers and acquisitions. In October 2020, for example, the Central Testing Laboratory at Abu Dhabi Quality & Conformity Council established a proficiency testing program with Biogenix Lab in order to validate the competence of medical laboratories that are performing COVID-19 test.
Because of the capital requirements, it is hard to enter the market without being a part of the most prominent players. The following are some of the most prominent players in global laboratory proficiency testing:
LGC Limited
American Proficiency Institute
American College of Pathologists
Bio-Rad Laboratories Inc.
Randox Laboratories Ltd.
QACS - The Challenge Test Laboratory
Merck & Co., Inc.
Weqas
ERA
AOAC International
BIPEA
NSI Lab Solutions
Absolute Standards, Inc.
RCPA
NEQAS UK
INSTAND
Up Market Research published a new report titled “Laboratory Proficiency Testing Market research report which is segmented by Technology (PCR, Cell Culture), by Industry Scope (Pharmaceuticals, Clinical Diagnostics), By Players/Companies RCPA, BIPEA, College of American Pathologists, QACS - The Challenge Test Laboratory, Randox Laboratories Ltd, Merck & Co Inc, Bio-Rad Laboratories Inc, Weqas, American Proficiency Institute, LGC Limited, ERA, INSTAND, Absolute Standards Inc, NSI Lab Solutions, UK NEQAS, AOAC International”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Laboratory Proficiency Testing Market Research Report |
By Technology | PCR, Cell Culture |
By Industry Scope | Pharmaceuticals, Clinical Diagnostics |
By Companies | RCPA, BIPEA, College of American Pathologists, QACS - The Challenge Test Laboratory, Randox Laboratories Ltd, Merck & Co Inc, Bio-Rad Laboratories Inc, Weqas, American Proficiency Institute, LGC Limited, ERA, INSTAND, Absolute Standards Inc, NSI Lab Solutions, UK NEQAS, AOAC International |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 229 |
Number of Tables & Figures | 161 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Technology (PCR, Cell Culture), by Industry Scope (Pharmaceuticals, Clinical Diagnostics).
Laboratory Proficiency Testing Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Laboratory Proficiency Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Laboratory Proficiency Testing Market Report:
Some other reports from this category!